» Articles » PMID: 9813223

Ascorbate Modulates Glutamate-induced Excitations of Striatal Neurons

Overview
Journal Brain Res
Specialty Neurology
Date 1998 Nov 14
PMID 9813223
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

To assess the role of ascorbate (AA), an antioxidant vitamin, in modulating striatal activity, single-unit recording was combined with iontophoresis in awake, unrestrained rats. Brief applications of AA (20 s, 5-80 nA) elicited few changes in either basal activity or activity evoked by continuous application of glutamate (GLU), but relatively high AA ejection currents (>40 nA) often inhibited fast-firing units. Comparable results were obtained with the antioxidant isomer, iso-AA, suggesting the AA-induced inhibition represents a high-dose, antioxidant effect. When applied for prolonged periods (2-4 min) at doses that failed to alter basal activity, AA either enhanced or attenuated the excitatory response to test pulses of GLU. The AA-induced enhancement occurred more frequently (16 vs. 6 applications) and was characterized by a more rapid (shorter onset and peak latencies) and more pronounced (greater peak magnitude) excitation to GLU without an evident change in offset latency. In most cases, further increases in AA ejection current attenuated the GLU response. Iso-AA, in contrast, had only inhibitory effects, which occurred at moderate- to high-dose applications. Collectively, these results suggest that AA, apart from its antioxidant effects, modulates phasic changes in striatal excitability induced by GLU. Because extracellular levels of striatal AA fluctuate in relation to behavioral activation, this neuromodulatory action of AA may contribute to behaviorally relevant changes in sensorimotor responsivity.

Citing Articles

L-Ascorbic Acid 2-Phosphate Attenuates Methylmercury-Induced Apoptosis by Inhibiting Reactive Oxygen Species Accumulation and DNA Damage in Human SH-SY5Y Cells.

Zuo K, Xu Q, Wang Y, Sui Y, Niu Y, Liu Z Toxics. 2023; 11(2).

PMID: 36851019 PMC: 9967424. DOI: 10.3390/toxics11020144.


Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.

Rebec G Antioxid Redox Signal. 2013; 19(17):2115-28.

PMID: 23642110 PMC: 3869431. DOI: 10.1089/ars.2013.5387.


Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine.

Planert H, Berger T, Silberberg G PLoS One. 2013; 8(3):e57054.

PMID: 23469183 PMC: 3585935. DOI: 10.1371/journal.pone.0057054.


Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.

Estrada-Sanchez A, Rebec G Basal Ganglia. 2012; 2(2):57-66.

PMID: 22905336 PMC: 3418680. DOI: 10.1016/j.baga.2012.04.029.


Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.

Miller B, Dorner J, Bunner K, Gaither T, Klein E, Barton S J Neurochem. 2012; 121(4):629-38.

PMID: 22332910 PMC: 3325322. DOI: 10.1111/j.1471-4159.2012.07691.x.